Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

1. Oaknin, A.
2. Moore, K.
3. Meyer, T.
4. López-Picazo González, J.
5. Devriese, L.A.
6. Amin, A.
7. Lao, C.D.
8. Boni, V.
9. Sharfman, W.H.
10. Park, J.C.
11. Tahara, M.
12. Topalian, S.L.
13. Magallanes, M.
14. Molina Alavez, A.
15. Khan, T.A.
16. Copigneaux, C.
17. Lee, M.
18. Garnett-Benson, C.
19. Wang, X.
20. Naumann, R.W.